Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Dairou

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Nucleic Acids Research|May 24, 2022
Hexokinase 2 is a transcriptional target and a positive modulator of AHR signallingManon Watzky, Solène Huard, Ludmila Juricek, et al.
FEBS Letters|July 2, 2010
The human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): mechanism and kineticsNilusha Ragunathan, Florent Busi, Benjamin Pluvinage, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cellsNicole R West, Mattias F Lindberg, Julien Dairou, et al.
The Journal of Biological Chemistry|May 7, 2009
An acetyltransferase conferring tolerance to toxic aromatic amine chemicals: molecular and functional studiesMarta Martins, Fernando Rodrigues-Lima, Julien Dairou, et al.
Disease Models & Mechanisms|June 29, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cellsNicole R West, Mattias F Lindberg, Julien Dairou, et al.
ACS Nano|April 30, 2011
Carbon black nanoparticles impair acetylation of aromatic amine carcinogens through inactivation of arylamine N-acetyltransferase enzymesElodie Sanfins, Julien Dairou, Salik Hussain, et al.
FEBS Letters|March 4, 2006
Insight into the structure of Mesorhizobium loti arylamine N-acetyltransferase 2 (MLNAT2): a biochemical and computational studyJulien Dairou, Delphine Flatters, Alain F Chaffotte, et al.
Biochemistry|May 22, 2007
Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistanceBenjamin Pluvinage, Julien Dairou, Odile M Possot, et al.
Toxicology and Applied Pharmacology|March 3, 2009
Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidantsJulien Dairou, Emile Petit, Nilusha Ragunathan, et al.
FEBS Letters|November 26, 2013
Skeletal muscle glycogen phosphorylase is irreversibly inhibited by mercury: molecular, cellular and kinetic aspectsXiming Xu, Cécile Mathieu, Solène Emmanuelle Boitard, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Nucleic Acids Research|May 24, 2022
Hexokinase 2 is a transcriptional target and a positive modulator of AHR signallingManon Watzky, Solène Huard, Ludmila Juricek, et al.
FEBS Letters|July 2, 2010
The human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): mechanism and kineticsNilusha Ragunathan, Florent Busi, Benjamin Pluvinage, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cellsNicole R West, Mattias F Lindberg, Julien Dairou, et al.
The Journal of Biological Chemistry|May 7, 2009
An acetyltransferase conferring tolerance to toxic aromatic amine chemicals: molecular and functional studiesMarta Martins, Fernando Rodrigues-Lima, Julien Dairou, et al.
Disease Models & Mechanisms|June 29, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cellsNicole R West, Mattias F Lindberg, Julien Dairou, et al.
ACS Nano|April 30, 2011
Carbon black nanoparticles impair acetylation of aromatic amine carcinogens through inactivation of arylamine N-acetyltransferase enzymesElodie Sanfins, Julien Dairou, Salik Hussain, et al.
FEBS Letters|March 4, 2006
Insight into the structure of Mesorhizobium loti arylamine N-acetyltransferase 2 (MLNAT2): a biochemical and computational studyJulien Dairou, Delphine Flatters, Alain F Chaffotte, et al.
Biochemistry|May 22, 2007
Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistanceBenjamin Pluvinage, Julien Dairou, Odile M Possot, et al.
Toxicology and Applied Pharmacology|March 3, 2009
Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidantsJulien Dairou, Emile Petit, Nilusha Ragunathan, et al.
FEBS Letters|November 26, 2013
Skeletal muscle glycogen phosphorylase is irreversibly inhibited by mercury: molecular, cellular and kinetic aspectsXiming Xu, Cécile Mathieu, Solène Emmanuelle Boitard, et al.
Pageof 12